Latest Commercial Growth News

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

Winton Land Limited reports a sharp 60% revenue decline in its interim results for H1 FY26 but narrows its net loss and progresses key development projects amid a cautious economic backdrop.

Eden Innovations has taken a major step in strengthening its balance sheet by converting a $2.2 million loan into equity, positioning the company debt free and ready to accelerate growth.

RLF AgTech has appointed Stuart Upton as CEO, marking a strategic shift towards disciplined execution and commercial scaling of its crop nutrition and carbon platforms. Former Acting Managing Director Gavin Ball returns to Executive Director to focus on international expansion.

BPH Global has secured a $1 million strategic placement to accelerate growth of its Indonesian seaweed trading operations, backed by record sales and robust infrastructure. This capital injection aims to boost trading volumes and pave the way for higher-margin revenue streams.

Klevo Rewards Limited’s subsidiary Fly Wallet has secured key Mastercard compliance and earned over AUD 550,000 in incentives, marking a significant step in its payments platform evolution.

GCM Corporation is advancing its commercialisation strategy with multiple prototypes across key global markets and sectors, aiming for revenue in the first half of 2026.

OncoSil Medical Limited has announced a fully underwritten $2 million entitlement offer alongside a $6 million placement to fund its clinical and commercial growth initiatives. The capital raising includes new shares and options, with shareholder approvals pending for certain components.

BluGlass Limited has extended its contract with the U.S. Department of War by A$1.05 million and appointed a refreshed Board to accelerate its commercial growth in visible laser technology. The company is advancing its GaN laser portfolio amid a US$100 million project pipeline and ongoing R&D investments.

Alexium International Group has acquired Microtek Laboratories’ microencapsulation business, marking a strategic pivot to manufacturing-led growth and raising $4.6 million to fund expansion. Despite a slight sales dip, the company is poised for a stronger 2026 with new product lines and military trials underway.

Janus Electric reports operational progress with validated technology and increased revenue, while focusing on commercial execution and cost discipline under new CEO Ben Hutt. Funding remains a critical factor for sustaining growth.

Fluence Corporation reported robust revenue and EBITDA growth in FY 2025, driven by strong contributions from its Ivory Coast project and expanding Smart Product Solutions. Leadership changes aim to accelerate growth as the company eyes continued momentum in 2026.